ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 198 filers reported holding ACORDA THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 7.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $5,203,000 | -40.7% | 220,000 | -50.6% | 0.02% | -44.4% |
| Q2 2017 | $8,767,000 | -2.0% | 445,000 | +4.5% | 0.03% | -3.6% |
| Q1 2017 | $8,946,000 | +1633.7% | 426,000 | +2085.7% | 0.03% | +1300.0% |
| Q1 2016 | $516,000 | -35.0% | 19,490 | +5.1% | 0.00% | -33.3% |
| Q4 2015 | $794,000 | +63.7% | 18,550 | +1.3% | 0.00% | +50.0% |
| Q3 2015 | $485,000 | -24.2% | 18,310 | -4.6% | 0.00% | 0.0% |
| Q2 2015 | $640,000 | +2.6% | 19,200 | +2.3% | 0.00% | 0.0% |
| Q1 2015 | $624,000 | -13.0% | 18,760 | +6.9% | 0.00% | -33.3% |
| Q4 2014 | $717,000 | +85.8% | 17,550 | +53.9% | 0.00% | +200.0% |
| Q3 2014 | $386,000 | +0.5% | 11,400 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $384,000 | -10.3% | 11,400 | +0.9% | 0.00% | -50.0% |
| Q1 2014 | $428,000 | +29.7% | 11,300 | 0.0% | 0.00% | +100.0% |
| Q4 2013 | $330,000 | -14.7% | 11,300 | 0.0% | 0.00% | -50.0% |
| Q3 2013 | $387,000 | +3.8% | 11,300 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $373,000 | – | 11,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 428,000 | $8,046,000 | 1.90% |
| SCOPIA CAPITAL MANAGEMENT LP | 4,532,067 | $85,203,000 | 1.61% |
| DLD Asset Management, LP | 247,300 | $4,656,000 | 1.52% |
| Broadfin Capital, LLC | 644,153 | $12,110,000 | 1.34% |
| Perceptive Advisors | 720,000 | $13,536,000 | 0.96% |
| DLD Asset Management, LP | 135,493 | $2,547,000 | 0.83% |
| Malaga Cove Capital, LLC | 51,013 | $971,000 | 0.64% |
| Baker Brothers Advisors | 3,301,791 | $62,074,000 | 0.61% |
| Worth Venture Partners, LLC | 29,300 | $551,000 | 0.59% |
| Spark Investment Management LLC | 327,900 | $6,164,000 | 0.51% |